Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
RGNX
$10.77
+0.98%
RGNX · REGENXBIO Inc.
$10.77
+0.11 (+0.98%)
At close · Aug 14
Market Cap
$710.63M
Shares
66.01M
All earnings calls
Earnings call · FY2026 Q2
REGENXBIO Inc. Q2 FY2026 Earnings Call
REGENXBIO Inc. Q2 FY2026 Earnings Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$108.02M
+405.7% YoY
Diluted EPS
$0.43
Net income
$22.71M
Research materials
Open the source you need; every reader stays inside this workspace.
Listen and read together
Transcript
The spoken word highlights as audio plays. Select any word to seek to that moment.
43:13
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document